Atlas Trials

Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder

Clinical trial NCT02737033 · UNKNOWN

Trial details

NCT number
NCT02737033
Sponsor
Hospital de Clinicas de Porto Alegre
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity Disorder
Start date
2016-04-01
Primary completion
2021-03-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.